Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Immunol. 2007 May;27(3):233-45. Epub 2007 Mar 11.

Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Author information

  • 1Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India.

Abstract

Initially used as a replacement therapy for immunodeficiency diseases, intravenous immunoglobulin (IVIg) is now widely used for a number of autoimmune and inflammatory diseases. Considerable progress has been made in understanding the mechanisms by which IVIg exerts immunomodulatory effects in autoimmune and inflammatory disorders. The mechanisms of action of IVIg are complex, involving modulation of expression and function of Fc receptors, interference with activation of complement and the cytokine network and of idiotype network, regulation of cell growth, and effects on the activation, differentiation, and effector functions of dendritic cells, and T and B cells.

PMID:
17351760
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk